Metraipolis › archive › dc_46644fd46897
The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer… — Europe PMC PMID:41847707
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41847707
- DOI
- 10.3389/fonc.2026.1713273
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T10:01:19.579Z
- SHA-256 of the archived text
49b3909225529bc0c16eb7174330c088158c88ac04f13c050fcfa394f49a8bdd- Stable URL of this page
https://metraipolis.com/documento/dc_46644fd46897
How to cite
The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer… — Europe PMC PMID:41847707 — Europe PMC (en), https://europepmc.org/article/MED/41847707 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_46644fd46897 (Metraipolis archive dc_46644fd46897, sha256 49b3909225529bc0c16eb7174330c088158c88ac04f13c050fcfa394f49a8bdd)
BibTeX
@misc{dc46644fd46897,
title = {The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer… — Europe PMC PMID:41847707},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41847707},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_46644fd46897; sha256 49b3909225529bc0c16eb7174330c088158c88ac04f13c050fcfa394f49a8bdd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41847707. Agents can read the archived copy with the MCP tool read_document.